A Controlled Study of Ranitidine for the Prevention of Recurrent Hemorrhage from Duodenal Ulcer
- 10 February 1994
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 330 (6), 382-386
- https://doi.org/10.1056/nejm199402103300602
Abstract
Hemorrhage is the most common complication of duodenal ulcer disease, but there is little information about the effectiveness and safety of long-term maintenance therapy with histamine H2-receptor blockers.Keywords
This publication has 16 references indexed in Scilit:
- A Randomized Study of Maintenance Therapy with Ranitidine to Prevent the Recurrence of Duodenal UlcerNew England Journal of Medicine, 1989
- Long term management of duodenal ulcer in general practice: How best to use cimetidine?BMJ, 1988
- Economic Assessment of Peptic Ulcer Disease TreatmentsScandinavian Journal of Gastroenterology, 1988
- Maintenance Ranitidine Treatment after Haemorrhage from a Duodenal Ulcer: A 3-Year StudyScandinavian Journal of Gastroenterology, 1988
- Maintenance Treatment with Cimetidine in Peptic Ulcer Disease for Up to 4 YearsScandinavian Journal of Gastroenterology, 1987
- CONTROLLED TRIAL OF Nd-YAG LASER PHOTOCOAGULATION IN BLEEDING PEPTIC ULCERSThe Lancet, 1986
- Final Report on the United States Multicenter Trial Comparing Ranitidine to Cimetidine as Maintenance Therapy Following Healing of Duodenal UlcerJournal of Clinical Gastroenterology, 1985
- RANITIDINE AND CIMETIDINE IN PREVENTION OF DUODENAL ULCER RELAPSE *1A Double-blind, Randomised, Multicentre, Comparative TrialThe Lancet, 1984
- Ranitidine in the prevention of gastric and duodenal ulcer relapse.Gut, 1983
- CONTROLLED TRIAL OF ARGON LASER PHOTOCOAGULATION IN BLEEDING PEPTIC ULCERSThe Lancet, 1981